TRIM24, which contains both a PHD- and a bromodomain interacting with the dual histone mark H3K4me0/H3K23Ac, is an oncogenic transcriptional coactivator overexpressed in breast [139] and prostate [140] adenocarcinoma, along with glioblastoma, in which TRIM24 is a Stat3 coactivator [141]. Here, TRIM24 is linked to adenocarcinoma.